Acutus medical announces preliminary unaudited fourth quarter and full year 2022 results and appointment of chief financial officer

Carlsbad, calif., jan. 09, 2023 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the fourth quarter and full year 2022. the company also announced the appointment of takeo mukai as senior vice president & chief financial officer.
AFIB Ratings Summary
AFIB Quant Ranking